2023-11-01 11:39:28
Recently (end of October), Hubei, Jiangxi and other places have successively announced the results of the national centralized procurement of proprietary Chinese medicines. The National Centralized Procurement of Chinese Patent Medicines consists of 30 provinces, autonomous regions and municipalities forming a national purchasing alliance. The drugs cover a variety of clinically commonly used Chinese patent medicines in 6 therapeutic areas: internal medicine, orthopedics, ophthalmology, oncology, cardiovascular system and gynecological drugs. 68 Among them, the average reduction of selected representative products was 49%, further reducing the burden of drug costs on patients.
Areas of the Centralized Purchasing Alliance of Chinese Patent Medicines can save 4.5 billion yuan in drug costs every year
The country has carried out many centralized purchases of chemicals before. The Chinese patent medicines targeted by this centralized procurement have no consistent evaluation in terms of drug ingredients and efficacy, and the market concentration is high. The rules for the centralized procurement of Chinese patent medicines have been adjusted to improve the quality and efficiency of the selected drugs and benefit the people.
Cui Dan, a researcher at Wuhan University Global Health Research Center:There is a pre-quality evaluation process, including considering the company’s production scale, past reputation, and then including whether it has been on the black list of the NMPA (National Medical Products Administration), has had any safety incidents, etc., as a points, and bring in its price factors to make a comprehensive evaluation. Avoid the phenomenon of bad money driving out good money.
In addition, experts said that the price reduction space for centralized procurement of Chinese patent medicines is reasonable, which will guide the formation of market prices for Chinese patent medicines, allowing pharmaceutical manufacturers to win the market through product quality and innovation, and reduce the burden on the public.
Zhu Xiaoping, Director of the Pharmaceutical Pricing and Bidding and Procurement Division of Hubei Provincial Medical Security Bureau:It is estimated that the alliance region can save 4.5 billion yuan in drug costs every year. In accordance with the unified arrangements and deployment of the National Medical Insurance Administration, provinces in the alliance region have successively carried out implementation work, and it is expected that all implementation will be implemented by mid-November.
Explore inter-provincial alliance centralized procurement of Chinese herbal medicines, traditional Chinese medicine formula granules, etc.
In addition to Chinese patent medicines, in recent years, various regions have piloted centralized procurement of Chinese medicinal materials, Chinese medicinal pieces, and Chinese medicinal granules through provincial and inter-provincial alliances to explore centralized procurement models in areas other than chemicals.
Traditional Chinese medicine formula granules are granules made by extracting and concentrating single-flavored traditional Chinese medicine pieces, which are convenient for patients to take. On October 27, the country’s first inter-provincial alliance centralized purchasing of traditional Chinese medicine formula granules opened bids in Texas. 200 varieties of traditional Chinese medicine formula granules, including astragalus, dangshen, and angelica, saw an average price reduction of 50.77%, covering a market of 3.715 billion yuan in 15 alliance provinces including Shanxi and Liaoning. scale. All traditional Chinese medicine formula granules purchased this time meet national drug standards.
Liu Zhi, Director of the Pharmaceutical Pricing and Bidding and Procurement Division of Shandong Provincial Medical Security Bureau:Since 2021, the drug regulatory department has promoted the formulation of national and provincial drug standards for traditional Chinese medicine formula granules. With centralized procurement having quality standards to follow, it can also promote the popularization and use of high-quality formula granules with quality standards among the masses through centralized procurement.
In recent years, the number of formula granule manufacturers has increased significantly, and market competition is relatively sufficient. After implementation, it will save the alliance provinces a total of 1.665 billion yuan every year. It is expected that in January next year, patients in the alliance area will be able to use high-quality and affordable centralized Chinese medicine formula granule products.
(Source of article: CCTV News Client)
Article source: CCTV News Client
Original title: The average reduction is 49%, and the results of the national centralized procurement of proprietary Chinese medicines are gradually implemented.
Solemnly declare:Oriental Fortune publishes this content to disseminate more information. It has nothing to do with the position of this site and does not constitute investment advice. Operate accordingly at your own risk.
1698874403
#average #decrease #results #national #centralized #procurement #proprietary #Chinese #medicines #gradually #implemented_Oriental #Fortune #Network
